We are collecting data and biological samples from people with infectious or inflammatory conditions of the bowel such as celiac disease, colitis, and Inflammatory Bowel Disease (IBD) and from people who do not have bowel disease to get a better understanding of these diseases.
14 Studies found
Hepatitis C Therapeutic Registry And Research Network, A Longitudinal, Observational Study (Hcv-Target)
This is an observational study collecting information about patients diagnosed with chronic Hepatitis C viral (HCV) infection who are being treated with approved anti-HCV therapies. The purpose of this research study is to collect information about patients who are being treated for chronic hepatitis C virus (HCV).
Seeking healthy adults and adults who have been suffering influenza-like illness for no more than 14 days for a study of how the flu or flu-like infections affect their blood cells.
Seeking children who have been diagnosed with influenza in the past 7 days and healthy children willing to donate a blood sample for a study of how influenza affects blood cells of children.
An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.
Seeking men and women who have been hospitalized with the coronavirus COVID-19 for a study of an experimental drug.
This program provides access to investigational convalescent plasma for hospitalized patients infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Seeking people, local to central Massachusetts, who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients.
Seeking men and women who are at high risk of developing COVID-19 following an exposure to an infected person for a study to evaluate whether convalescent plasma, which is made from blood donated from a person who has recovered from COVID-19, might prevent or lessen the severity of COVID-19.
Convalescent Plasma To Limit Coronavirus Associated Complications For People Being Treated Outside The Hospital
Seeking men and women who are being treated outside of the hospital for their COVID-19 infection for a study of an investigational blood product made from blood plasma donated by people who have recovered from COVID-19, known as convalescent plasma.
Seeking men and women who are in the hospital and diagnosed with COVID-19 for a study of an investigational drug to see if it acts as an anti-viral and anti-inflammatory treatment for COVID-19 infection.
Seeking people aged 12 and older who have been diagnosed with COVID-19 for an experimental treatment made from blood donated by people who have recovered from COVID-19.
Study Of An Investigational Dietary Supplement In People Treated Outside Of The Hospital For Covid-19 Infection
Seeking men and women whose mild to moderate COVID-19 infection is being treated outside of the hospital for a study of an investigational dietary supplement on the bacteria of their digestive system or gut microbiome.
Seeking hospitalized men and women who are receiving mechanical ventilation due to COVID-19 for a study to evaluate the efficacy and safety of an investigational drug.